US equities |
NVDA $166.19 ▲+0.00% AMD $585.30 ▲+0.00% MSFT $523.00 ▲+0.00% MU $798.44 ▲+0.00% SNDK $937.46 ▲+0.00% SPCX $139.94 ▲+0.00% SKHY $137.71 ▲+0.00% TSLA $397.45 ▲+0.00%
FinancialContent

Journey Medical Corporation - Common Stock (NQ:DERM)

4.390 UNCHANGED
Delayed Quote Updated: 4:00 PM EST, Nov 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Journey Medical Corporation - Common Stock

< Previous 1 2 3 4 Next >
News headline image
Journey Medical (DERM) Q3 2026 Earnings Call Transcript ↗
Prescriptions rose and margins improved as the rosacea drug gained payer traction. 
Via The Motley Fool
Topics Earnings
News headline image
What Journey Medical (DERM) Said on Its Q3 Earnings Call ↗
Journey Medical (NASDAQ:DERM) reported higher third-quarter revenue and a narrower net loss as sales of its rosacea treatment Emrosi grew, while executives said broader insurance coverage could support... 
Via MarketBeat
Topics Earnings
News headline image
Journey Medical (DERM) Q2 2026 Earnings Call Transcript ↗
Emrosi prescriptions hit 14,000 in July as payer coverage expands and margins improve. 
Via The Motley Fool
Topics Earnings
Journey Medical Corp (NASDAQ:DERM) Slightly Misses Q1 2026 Revenue Expectations as Stock Rises on Strong Emrosi Growth and Full-Year Profitability Outlook ↗
Via Chartmill
Journey Medical Corp (NASDAQ:DERM) Shares Drop 8.8% After Q4 Revenue Miss ↗
Via Chartmill
News headline image
Earnings Scheduled For November 12, 2025 ↗
 
Via Benzinga
News headline image
Examining the Future: Journey Medical's Earnings Outlook ↗
 
Via Benzinga
News headline image
Journey Medical Q2 Earnings Call Highlights ↗
Journey Medical (NASDAQ:DERM) reported higher second-quarter revenue and a sharply narrower net loss as sales of its rosacea treatment EMROSI continued to grow, supported by rising prescription volume,... 
Via MarketBeat
Topics Earnings
News headline image
Journey Medical (DERM) Q1 2026 Earnings Transcript ↗
Journey Medical (DERM) Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM
From Pomerantz LLP
Via GlobeNewswire
Top movers analysis one hour before the close of the markets on 2026-03-26: top gainers and losers in today's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Insights into Journey Medical's Upcoming Earnings ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
CoreWeave, CAVA Group, Journey Medical And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
What's going on in today's pre-market session ↗
Wondering what's happening in Wednesday's pre-market session? Find an overview in this article. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Sapiens International Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket ↗
Shares of Sapiens International Corporation NV (NASDAQ:SPNS) rose sharply in pre-market trading after it announced on Wednesday that it will be acquired by global private equity firm Advent in an... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
After the closing bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Top 3 Health Care Stocks That May Crash In Q2 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 26, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 12, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 14, 2025 ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
What's Going On With Journey Medical Stock Today? ↗
Journey Medical (NASDAQ:DERM) shares are trading higher Monday after the company announced the U.S. Food and Drug Administration approved its Emrosi drug for the treatment of rosacea. 
Via Benzinga
< Previous 1 2 3 4 Next >